Summary of the Article: Special Issue of Cancer Biology & Medicine focuses on Cervical Cancer Elimination
this article highlights a special issue of the journal Cancer Biology & Medicine dedicated to the global elimination of cervical cancer. Released to coincide with the 30th anniversary of the Fourth World Conference on Women and the upcoming 2025 World Women’s Summit in beijing, the issue emphasizes that cervical cancer is uniquely positioned to be eliminated thru vaccination, screening, and early treatment.
Key takeaways from the special issue:
* Global Disparities & China‘s Role: The issue addresses global inequalities in cervical cancer rates and highlights China’s notable contributions to research and elimination efforts.
* Multi-faceted Approach: It features research spanning epidemiology, policy analysis, digital innovation, economic evaluation, and novel therapeutics.
* Specific advances: Notable studies include:
* Policy modeling for resource-sensitive elimination strategies.
* Analysis of cervical cancer trends in China compared to other Asia-Pacific countries.
* Evaluation of a bilingual digital colposcopy education tool (iDECO) improving diagnostic accuracy.
* Progress of a promising HPV16 protein vaccine showing tumor regression in preclinical models.
* Research on HPV vaccination willingness and innovative screening programs.
* Call to Action: The issue stresses the need for strong policy alignment and international cooperation to achieve elimination, emphasizing that it’s a matter of both public health and gender equity.
Quote from Guest Editor Professor Youlin Qiao: “Cervical cancer is the only malignancy we can realistically eliminate through vaccination, screening, and early treatment… By combining science, policy, and equity, we can ensure that no woman is left behind.”
Ultimately, the special issue serves as a progress report and a call for continued collaboration to make cervical cancer elimination a reality within our lifetime.
Source: Chinese Academy of Sciences
Journal: Cancer Biology & Medicine (specifically, the September 2025 issue)
DOI: 10.20892/j.issn.2095-3941.2025.0370 (for one specific study on the HPV16 vaccine)
